Summit Global Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,825
| Closed | -$1.14M | – | 503 |
|
|
2025
Q1 | $1.14M | Buy |
10,825
+6,407
| +145% | +$674K | 0.08% | 149 |
|
|
2024
Q4 | $473K | Buy |
+4,418
| New | +$473K | 0.03% | 371 |
|
|
2024
Q2 | – | Sell |
-16,171
| Closed | -$1.18M | – | 541 |
|
|
2024
Q1 | $1.18M | Sell |
16,171
-3,226
| -17% | -$236K | 0.09% | 182 |
|
|
2023
Q4 | $1.39M | Sell |
19,397
-2,685
| -12% | -$192K | 0.09% | 183 |
|
|
2023
Q3 | $1.32M | Buy |
22,082
+9,845
| +80% | +$590K | 0.09% | 170 |
|
|
2023
Q2 | $882K | Buy |
12,237
+3,837
| +46% | +$277K | 0.06% | 256 |
|
|
2023
Q1 | $618K | Buy |
+8,400
| New | +$618K | 0.05% | 319 |
|
|
2018
Q4 | – | Sell |
-5,450
| Closed | -$933K | – | 290 |
|
|
2018
Q3 | $933K | Hold |
5,450
| – | – | 0.13% | 119 |
|
|
2018
Q2 | $704K | Hold |
5,450
| – | – | 0.11% | 144 |
|
|
2018
Q1 | $562K | Buy |
+5,450
| New | +$562K | 0.09% | 183 |
|